Protalix BioTherapeutics
PLX
PLX
63 hedge funds and large institutions have $17.6M invested in Protalix BioTherapeutics in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 4 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
–
Holders Change %
0%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
19
Reduced
4
Closed
30
Calls
$379K
Puts
$58K
Net Calls
+$321K
Net Calls Change
-$351K
Top Buyers
1 |
BlackRock
New York
|
$4.99M |
2 |
Geode Capital Management
Boston,
Massachusetts
|
$1.22M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$718K |
4 |
State Street
Boston,
Massachusetts
|
$657K |
5 |
Renaissance Technologies
New York
|
$2.39M |